Skip to main content
. Author manuscript; available in PMC: 2018 Apr 18.
Published in final edited form as: Immunity. 2017 Apr 11;46(4):596–608. doi: 10.1016/j.immuni.2017.03.012

Figure 6. Increased H3K27me3 deposition occurs specifically in late-stage TE cells.

Figure 6

A) Tbx21, Tcf7, Foxo1, Bach2, and Id3 mRNA were measured in purified naïve (day 0) Ezh2f/f (solid) P14+ CD8+ T cells, and in Ezh2f/f (solid) and Ezh2f/f GzmBCre+ (open) P14+ CD8+ T cells from day 4.5 p.i. using qRT-PCR. Data are representative of 3 independent experiments (n=2–3 mice/group/experiment).

B) WT P14+ CD8+ T cells were purified from naïve (day 0) and LCMV-Armstrong infected mice at days 1.5, 4.5 (KLRG1Hi and KLRG1Lo populations), 10 (KLRG1HiIL7RLo TE and KLRG1LoIL7RHi MP populations), and 30 p.i., and then ChIP-qPCR was performed for H3K27me3 using primers to the Tcf7 TSS and Bach2 intron 1 (black). Region within Ttn served as a negative control (white) for H3K27me3 based on genome-wide H3K27me3 ChIP-seq analysis. Data are cumulative of four independent experiments (n=2–4 mice/group/experiment) with % of input for each sample normalized internally to the % of input for the day 30 sample, thereby calculating fold enrichment relative to the d30 sample as plotted. Data are expressed as mean ± SD. *p<0.05, **p<0.01. See also Figure S6.